AP461A - "Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives". - Google Patents

"Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives". Download PDF

Info

Publication number
AP461A
AP461A APAP/P/1994/000648A AP9400648A AP461A AP 461 A AP461 A AP 461A AP 9400648 A AP9400648 A AP 9400648A AP 461 A AP461 A AP 461A
Authority
AP
ARIPO
Prior art keywords
carbon atoms
radical
formula
compound
alkyl
Prior art date
Application number
APAP/P/1994/000648A
Other versions
AP9400648A0 (en
Inventor
Jean-Philippe Bascou
Joseph Gadras
Martial Lacroix
Joseph Perez
Original Assignee
Bayer Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9307663A external-priority patent/FR2706455B1/en
Application filed by Bayer Sas filed Critical Bayer Sas
Publication of AP9400648A0 publication Critical patent/AP9400648A0/en
Application granted granted Critical
Publication of AP461A publication Critical patent/AP461A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/30Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C07C243/32Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16Isothiocyanates
    • C07C331/18Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms
    • C07C331/22Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C331/24Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/80Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

An optically active

Description

Fungicidal optically active 2-imidazolin-5-one and
2-imidazoline-5-thione derivatives
The subject of the present invention is new optically active 2-imidazolin-5-one and 2-imidazoline5-thione derivatives for use in plant protection, and their process of preparation.
It also relates to fungicidal compositions based on these compounds and to a process for the treatment of fungal diseases of crops using these compounds .
The racemic compounds derived from 2imidazolin-5-ones and 2-imidazoline-5-thiones are described in European Patent Applications EP 551048 and EP 599749, and in International Application WO 94/01410.
It has now been discovered that one of the optical isomers of these compounds has a biological activity which is much greater than that of the other isomer and that of the racemic modification.
One object of the invention is therefore to provide new compounds which are useful in controlling fungal diseases of crops.
Another object of the invention is to provide new 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives which are active at a dose which is reduced with respect to that of the racemic derivatives.
It has now been found that these objects could be achieved by virtue of the products of the
V 9 0 0 / V 6 ,'d/dV
BAD ORIGINAL
AP C Ο Ο 4 6 1 invention, which are optically active 2-imidazolin-5one or 2-imidazoline-5-thione derivatives of general formula I:
t' c
( in which:
-W represents an oxygen or sulphur atom or an S=O group;
-M represents an oxygen or sulphur atom, or an optionally halogenated CH2 radical;
-p is an integer equal to 0 or 1;
* means the asymmetric carbon atom corresponding to a stereospecific configuration;
-R1 and R2 are different and represent:
- an alkyl or haloalkyl radical containing 1 to 6 carbon atoms or
- an alkoxyalkyl, alkylthioalkyl, alkylsulphonylalkyl, monoalkylaminoalkyl, alkenyl or alkynyl radical containing 2 to 6 carbon atoms or
- a dialkylaminoalkyl or cycloalkyl radical containing 3 to 7 carbon atoms or
V 9 0 0 / V 6 /d/dV
BAD ORIGINAL
AP Ο Ο Ο 4 6 1
- an aryl radical comprising phenyl, naphthyl/ thienyl, furyl, pyridyl, benzothienyl, benzofuryl, quinolyl, isoquinolyl or methylenedioxyphenyl, optionally substituted by 1 to 3 groups chosen from R‘ or
- an arylalkyl, aryloxyalkyl, arylthioalkyl or arylsulphonylalkyl radical, the terms aryl and alkyl having the definitions given above or
- R1 and R2 can form, with the carbon to which they are bonded on the ring, a carbocycle or a heterocycle having from 5 to 7 atoms, it being possible for these rings to be fused to a phenyl, optionally substituted by 1 to 3 groups chosen from R*;
- R3 represents:
- a hydrogen or an optionally halogenated Cj-Cj alkyl radical, when p is equal to 0 or (M)p is a CH2 radical,
- an optionally halogenated Cj-Cj alkyl radical, when (M)p represents an oxygen or sulphur atom;
- R4 represents:
- the hydrogen atom or
- an alkyl group containing 1 to 6 carbon atoms or
BAD ORIGINAL
AP Ο Ο Ο 4 6 1
- an alkoxyalkyl, alkylthioalkyl, haloalkyl, cyanoalkyl, thiocyanatoalkyl, alkenyl or alkynyl group containing 2 to 6 carbon atoms or
- a dialkylaminoalkyl, alkoxycarbonylalkyl or Nalkylcarbamoylalkyl group containing 3 to 6 carbon atoms or
- an Ν,Ν-dialkylcarbamoylalkyl group containing 4 to 8 carbon atoms or
- an aryl radical, comprising phenyl, naphthyl, thienyl, furyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, benzothienyl, benzofuryl, quinolyl, isoquinolyl or methylenedioxyphenyl, optionally substituted by 1 to 3 groups chosen from Rs or ( - an arylalkyl, aryloxyalkyl, ζ arylthioalkyl or arylsulphonylalkyl radical, the terms aryl and alkyl having the definitions given above;
-R5 represents:
- H, except when R4 is H, or
- an alkyl, haloalkyl, alkylsulphonyl or haloalkylsulphonyl radical containing 1 to 6 carbon atoms or
- an alkoxyalkyl, alkylthioalkyl, acyl, alkenyl, alkynyl, haloacyl,
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL £
AP Ο Ο Ο 4 6 1 alkoxycarbonyl, haloalkoxycarbonyl, alkoxyalkylsulphonyl or cyanoalkylsulphonyl radical containing 2 to 6 carbon atoms or
- an alkoxyalkoxycarbonyl, alkylthioalkoxycarbonyl or cyanoalkoxycarbonyl radical containing 3 to 6 carbon atoms or
- the formyl radical or
- a cycloalkyl, alkoxyacyl, alkylthioacyl, cyanoacyl, alkenylcarbonyl or alkynylcarbonyl radical containing 3 to 6 carbon atoms or
- a cycloalkylcarbonyl radical containing 4 to 8 carbon atoms or
- a phenyl; arylalkylcarbonyl, especially phenylacetyl and phenylpropionyl; arylcarbonyl, especially benzoyl, optionally substituted by 1 to 3 groups from R‘; thienylcarbonyl; furylcarbonyl;
pyridylcarbonyl; benzyloxycarbonyl; furfuryloxycarbonyl; tetrahydrofurfuryloxycarbonyl; thienylmethoxycarbony1; pyridylmethoxycarbonyl; phenoxycarbonyl or (phenylthio)carbonyl, the phenyl
AP/P/9 4 / 0 0 6 48
BAD ORIGINAL
AP Ο Ο Ο 4 6 1 being itself optionally substituted by 1 to 3 groups from R6; (alkylthio)carbonyl; (haloalkylthio) carbonyl;
(alkoxyalkylthio) carbonyl;
(cyanoalkylthio)carbonyl;
(benzylthio) carbonyl;
(furfurylthio)carbonyl;
(tetrahydrofurfurylthio) carbonyl;
(thienylmethylthio) carbonyl;
(pyridylmethylthio)carbonyl or arylsulphonyl radical or
- a carbamoyl radical, optionally monoor disubstituted by:
- an alkyl or haloalkyi group containing 1 to 6 carbon atoms or
- a cycloalkyl, alkenyl or alkynyl group containing 3 to 6 carbon ( atoms or , - an alkoxyalkyl, alkylthioalkyl or cyanoalkyl group containing 2 to 6 carbon atoms or
- a phenyl, optionally substituted by 1 to 3 Rs groups;
- a sulphamoyl group, optionally mono25 or disubstituted by:
- an alkyl or haloalkyi group containing 1 to 6 carbon atoms or
- a cycloalkyl, alkenyl or alkynyl
V 9 0 0 / V 6 /d/dV
BAD ORIGINAL ft
AP 0 0 0 4 6 1 group containing 3 to 6 carbon atoms or
- an alkoxyalkyl, alkylthioalkyl or cyanoalkyl group containing 2 to 6 carbon atoms or
- a phenyl, optionally substituted by 1 to 3 R* groups;
- an alkylthioalkylsulphonyl group containing 3 to 8 carbon atoms or a cycloalkylsulphonyl group containing 3 to 7 carbon atoms;
- R4 and Rs, taken together, can also form, with the nitrogen atom to which they are attached, a pyrrolidino, piperidino, morpholino or piperazino, optionally substituted by an alkyl containing 1 to 3 carbon atoms, group;
-R* represents:
- a halogen atom or
- an alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio or alkylsulphonyl radical containing 1 to 6 carbon atoms or
- a cycloalkyl, halocycloalkyl, alkenyloxy, alkynyloxy, alkenylthio or alkynylthio radical containing 3 to 6 carbon atoms or
- the nitro or cyano group or
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL ft
- an amino radical, optionally mono- or disubstituted by an alkyl or acyl radical containing 1 to 6 carbon atoms or an alkoxycarbonyl radical containing
2 to 6 carbon atoms
- a phenyl, phenoxy or pyridyloxy radical, these radicals optionally being substituted by 1 to 3 groups, which are identical or different, chosen from R7;
- R7 represents:
- a halogen atom chosen from fluorine, chlorine, bromine or iodine, or
- a linear or branched alkyl radical containing from 1 to 6 carbon atoms, or
- a linear or branched alkoxy or alkylthio radical containing from 1 to 6 carbon atoms, or
- a linear or branched haloalkoxy or haloalkylthio radical containing from 1 to 6 carbon atoms, or
- a nitrile radical, or
- a nitro radical.
The invention also relates to the agriculturally-acceptable salified forms of the compounds defined above.
According to a preferred variant of the invention, the optically active compounds according to the invention have the formula II:
4 9 0 0 / Ί 6 /d/dV
BAD ORIGINAL ft
AP ο Ο Ο 4 6 1
R\ .,Ν
N-R*
R5 in which the various symbols have the same meaning as in the formula I.
Finally, the compounds of the invention will advantageously be chosen from the compounds of formula II in which W represents an oxygen atom.
The method of preparation of the compounds of formula I is shown in the following paragraphs, according to two process variants A and B. The symbols represented in formula I, which appear in this description of the method of preparation, retain the same meaning as in the general definition of the invention, unless another definition is expressly attributed to them.
AP/P/ 9 4 / 0 0 6 48
The examples below illustrate the optically active derivatives of formula I and their process of preparation.
The structures of all the derivatives illustrated were characterized using at least one of the following spectral techniques: proton NMR spectrometry, carbon-13 NMR spectrometry, infrared spectrometry and mass spectrometry, as well as the usual methods for measuring optical rotations. The enantiomeric excesses were determined either by chiral
BAD ORIGINAL
AP 0 0 0 4 6 1 io phase high performance liquid chromatography or by NMR.
In the tables below, the phenyl, methyl and ethyl radicals are represented by Ph, Me and Et respectively.
Variant A;
First stage:
In a first stage of this variant, a description is given of the preparation of the optical isomers of formula I from α-amino acids which are optically pure or greatly enriched in one enantiomer. Optically active compound greatly enriched in a specific enantiomer is understood to mean a compound containing at least 80 %, preferably 95 %, of this enantiomer.
The optical isomers of formula I are prepared according to three series of processes, depending on the meaning of the (M)P-RJ group.
1) Preparation of the compounds of formula I in which p = 1 and M = S and W « 0:
The compounds of formula I in which p « 1 and M = S and W = 0 are prepared by reaction of the compound of formula III:
BAD ORIGINAL $
AP Ο Ο Ο 4 6 1
in which W represents an oxygen atom, with the compound of formula RSX, in which X represents the chlorine, bromine or iodine atom or the sulphate group or an alkylsulphonyloxy or arylsulphonyloxy group, alkyl and aryl being as defined above for R1 and R2. The reaction is carried out in a solvent and in the presence of a base. It is possible to use, as base, an alkoxide, for example potassium tert-butoxide, an alkali metal or alkaline earth-metal hydroxide, an alkali metal carbonate or a tertiary amine. It is possible to use, as solvent, ethers, cyclic ethers, alkyl esters, acetonitrile, alcohols containing 1 to 3 f carbon atoms or aromatic solvents, for example tetrahydrofuran, at a temperature between -5°C and +80eC.
A variant of the method described above consists in using the so-called one-pot process (Diagram 1) as described in European Patent Application EP 551048. This method consists in starting directly from the isothiocyanate of formula IV which is treated with a compound of formula V in a solvent and in the presence of a base as described above. The intermediate θ * 9 0 0 / 6 /d/dV
BAD ORIGINAL
AP Ο Ο Ο 4 6 1 of formula Ilia in the salt form is not isolated but is treated directly with the compound of formula R3X in which X has the same meaning as above
Rs la (Diagram 1)
Example 1; f + )- (4S)-4-methvl-2-methvlthio-4-phenvl-lphenylamino-2-imidazolin-5-one (Compound No. 11
682 g (3.08 mol) of methyl (+)-(2S)-2-phenyl2-(isothiocyanato)propionate, dissolved in 4 1 of anhydrous tetrahydrofuran, are introduced into a 20 1 reactor through which passes a stream of argon. Cooling is carried out to 15°C. 343 g (3.08 mol) of phenylhydrazine, dissolved in 2 1 of tetrahydrofuran, are run in over 30 min, the temperature being maintained between 15eC and 18eC. The mixture is kept stirring for 40 min and then cooled to 0*. A solution of 346 g (3.08 mol) of potassium tert-butoxide in 4 1 of tetrahydrofuran is run in over 1 hour, the
V 9 0 0 / V 6 /d/dV
BAD ORIGINAL
AP Ο Ο ο 4 θ 1 temperature being maintained at O°C. The mixture is stirred for a further 2 hours at 0*C and the formation of a pale-pink precipitate is observed. 216 ml (3.39 mol) of methyl iodide are run in over 15 min, the temperature being maintained between 0°C and 3°C, and the temperature is then allowed to rise to room temperature while continuing to stir for 2 hours. The reaction mixture is poured onto 5 1 of water. After separating, the aqueous phase is extracted with 3 times
3 1 of ethyl acetate. The combined organic phases are washed with 5 1 of water, dried over magnesium sulphate and then concentrated under reduced pressure. 1099 g of a brown solid are obtained. The latter is recrystallized from 2 1 of toluene.
There are obtained, after drying, 555 g of (+)-(4S)-4-methyl-2-methylthio-4-phenyl-1-phenylamino2-imidazolin-5-one in the form of an off-white solid melting at 138°C (Yield « 58 %; [e]”*c - + 61.1· (+ or - 2.9·)(c 0.86 in ethanol); degree of enantiomeric excess (e.e) > 98 %).
In the same way, the following analogous compounds of formula Ila were obtained:
AP/P/ 94/00648
BAD ORIGINAL $
AP Ο Ο Ο 4 6 1
Compound No. R* R* [e]D (c) Solvent M.p. (*C) rd (*)
1 Ph R +61* (0.8) EtOH 138 58
11 Ph 4-F +53* (0.7) EtOM 114 60
12 Ph 4-F (-) 114 66
13 3-FPh 4-F +52* (0.7) EtOH 130 70
14 3-FPh 4-F (-) - -
15 Ph 4-(4-FPh)O (*) 138 45
15 Ph 4-(4-FPh)O -13* (0.4) EtOH 139 71
The compound of formula III in which W represents an oxygen atom can be prepared by a cyclization reaction between an isothiocyanate of formula IV:
R:
I * ri -c-N=C=S I
CO.R
Μ 0 0 M 6 /d/dV in which R represents a alkyl, and a compound of formula V:
R'-N-NH2
R5
The cyclization reaction can be carried out in two ways:
BAD ORIGINAL d
AP Ο Ο Ο 4 6 1
- thermally: in this case, the mixture of the reactants is heated at a temperature between 110*C and 180°C in an aromatic solvent such as toluene, xylene or chlorobenzenes,
- in basic medium: the cyclization reaction is carried out in the presence of one equivalent of a base such as an alkali metal alkoxide, an alkali metal hydroxide or a tertiary amine. Under these conditions, cyclization takes place at a temperature between -10 and +80°C. It is possible to use, as solvent, especially ethers, cyclic ethers, alcohols, esters, DMF or DMSO.
Example 2: ( +) -(4S)-4-methvl-4-phenyl-l-phenvlamino-2thiohydantoin (Compound No. 7)
0.7 g (0.00316 mol) of methyl (+)—(2S)—2— isothiocyanato-2-phenylpropionate, diluted in 15 ml of dry tetrohydrofuran, is introduced into a 100 ml three-necked flask under a dry nitrogen atmosphere.
0.32 ml (0.00316 mol) of phenylhydrazine, diluted in 5 ml of tetrohydrofuran, is run in at 20eC in a single step. The temperature rises by 2°C. The medium is kept magnetically stirring for 30 min. Appearance of a dark-beige precipitate. The medium is neutralized with 0.4 ml of acetic acid and then treated with 20 ml of water. After separating, the aqueous phase is extracted with 3 times 20 ml of ethyl ether. The organic phases are combined, washed with 2 times 30 ml of water, dried over magnesium sulphate and then concentrated under
0*900/^6 Zd/dV
BAD ORIGINAL ft
AP Ο Ο Ο 4 6 1 reduced pressure. The solid residue obtained is chromatographed on a silica column, using an eluent mixture composed of heptane and ethyl acetate in the proportions 50/50.
0.55 g of (+)-(4S)-4-methyl-4-phenyl-lphenylamino-2-thiohydantoin is collected in the form of a beige solid melting at 167*C {Yield 58 %; [a]£7c = +86’ (+ or - 3.2*) (c 0.8 in methanol)).
The isothiocyanates of formula IV can be 10 prepared according to one of the processes mentioned in
Sulfur Reports, Volume 8 (5), pages 327-375 (1989), from the e-amino acid of formula VI via the amino ester of formula X:
R:
R.'
NH.
co2h
nh2 eoiR
O ·<
<x c
c
VI in a way well known to those skilled in the art.
Example 3: methyl ( +) -(2S)-2-isothiocyanato-2-phenylpropionate (Compound No. 8)
780 g (3.61 mol) of methyl (+)-(2S)-2-amino2-phenylpropionate hydrochloride and then 3.4 1 of 20 water are introduced into a 20 1 reactor. The temperature is brought to 2O’C. 3.4 1 of toluene are added and then 911 g (10.8 mol) of sodium
BAD ORIGINAL A hydrogencarbonate are added portionwise over 1 hour.
The temperature falls to 8-9*C. 276 ml (3.61 mol) of thiophosgene are run in over 2 hours. The reaction is accompanied by an evolution of gas and by a rise in temperature, which reaches 24°C at the end of the addition. The medium is kept stirring for a further 2 hours. After separating, the aqueous phase is extracted with 2 1 of toluene. The combined toluene phases are washed with 4 1 of water and then dried over magnesium t 10 sulphate. The solution is concentrated under reduced pressure.
There are obtained 682 g of methyl (+)-(2S)2-isothiocynanato-2-phenylpropionate in the form of a slightly coloured oil (Yield » 85 %; [a]”’c “ +16* (+ or
- 6.4°)(c = 0.78 in chloroform)).
In the same way, the following analogous compounds of formula IVa were obtained:
r
AP/P/ <) ί / 0 n fi 4 fl
BAD ORIGINAL
AP Ο Ο Ο 4 6 1
Compound No. Rs [“]D (<=) Solvent physical state Yd (%)
8 H +16* (0.78) CHC13 Oil 85
17 4-F (+/ Oil 72
18 4-F (-) Oil 80
19 4-(4-FPh)O (+) Oil 61
20 4-(4-FPh)O -110 (0.7) EtOH Oil 70
The amino esters of structure X can be obtained in a known way either by :
- diastereoselective amination of a prochiral compound followed by deprotection of the chiral moiety as described by R.S. Atkinson et al., Tetrahedron,
1992, 48, pp 7713-30,
- resolution of the corresponding racemate with a chiral compound as described by Y. Sugi and
S. Mitsui, Bull. Chem. Soc. Japan, 1969, 42, pp 298489.
- esterification of a chiral amino acid as described by D.J. Cram et al., J. Am. Chem. Soc., 1961,
83, pp 2183-89.
Example 4: methyl ( +) -(2SI-2-amino-2-phenylpropionate hydrochloride (Compound No. 91
611 g (3.7 mol) of (+)-2-aminophenylpropionic acid are charged to a 10 1 reactor, to which 5 1 of methanol are added. 819 ml (11.22 mol) of
BAD ORIGINAL
AP Ο Ο Ο 46 1 thionyl chloride are run onto the white suspension formed over 2 hours. The temperature reaches 58eC at the end of the addition. A significant evolution of gas is observed, which gas is trapped by a dilute sodium hydroxide solution. The medium is heated at 65*C for 14 hours. The solution is then concentrated under reduced pressure. The solid obtained is treated with 1 1 of toluene, filtered and then dried under vacuum.
There are obtained 762 g of methyl (+)-(2S)-2-amino-210 phenylpropionate hydrochloride in the form of a white powder melting at 162®C (Yield - 62 %; [a]”’c +53.3* (+ or - 3.3°) (c » 0.75 in water)).
In the same way, the following analogous compounds of formula Xa were obtained:
BAD ORIGINAL
AP Ο Ο Ο 4 6 1
Compound No. R4 (*]D (C) Solvent physical state M.p. CC) Yd (%)
9 H +54· (0.91) CHClj white crystals 162 62
21 4-F +61* (0.9) EtOH white solid 50-60 93
22 4-F (-) white solid 95
23 4-(4-FPh)O (+) white solid 87
24 4-(4-FPh)O (-) white solid 95
Methyl (+)-(2S)-2-amino-2-phenylpropionate is obtained by treating the hydrochloride prepared above with one equivalent of sodium hydrogencarbonate and then extracting with dichloromethane. It exists in the form of a colourless, slightly viscous oil ([a]£’’c = +54.8° (+ or - 2.7°) (c · 0.91 in chloroform), e.e >
%) .
2) Preparation of the optical isomers of formula I in which p 1 and M = O and W « 0:
The compounds of formula I in which p = 1 and M = 0 and W = 0 are prepared by reacting the corresponding compound of formula I for which p = 1 and M = S, according to a process described in European Patent Application EP 599749, with the alcohol of formula R3OH, in a solvent, in the presence of a strong base and at a temperature between 50 and 80°C. It is
BAD ORIGINAL ft
AJ> Ο Ο Ο 4 6 1 possible to use, as strong base, an alkali metal alkoxide R3OMet*, in which Met* represents an alkali metal or alkaline-earth metal, an alkali metal hydroxide or a strong organic base. The reaction is preferably carried out by taking the alcohol R3OH as solvent and by using the corresponding sodium alkoxide R3O*Na* as base.
Example 5; (+)-(4S)-4-methvl-2-methoxv-4-phenvl-lphenylamino-2-imidazolin-5-one (Compound No. 3)
80 ml of methanol and then 0.74 g (0.032 mol) of sodium, cut into thin pieces, are introduced into a 250 ml, three-necked, round-bottomed flask under a dry nitrogen atmosphere. 5 g (0.016 mol) of (+)-(4S)-4methy1-2-methylthio-4-phenyl-l-phenylamino-215 imidazolin-5-one are then added. The mixture is brought to reflux for 20 h. The mixture is cooled to room temperature and then acidified with 0.5 ml of acetic acid. The methanol is removed by distillation under reduced pressure and the residue obtained is then taken up in 50 ml of ethyl ether, washed with 3 times 40 ml of water, dried over magnesium sulphate and then the solution is concentrated under reduced pressure. A reddish honey is obtained which is purified by chromatography on a silica column with a 70/30 heptane/ethyl acetate mixture as eluent.
g of (+)-(4S)-4-methyl-2-methoxy-4-phenyll-phenylamino-2-imidazolin-5-one are obtained in the form of a pale-pink powder melting at 132°C (Yield «
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL
AP Ο Ο Ο 4 6 1
42%; [a]“‘c · +53.1° (+ or - 2.4°) (c 1 in methanol); e.e. > 98 %).
In the same way, the following analogous compounds of formula lb were obtained:
Compound No. R4 R6 [a]D (c) Solvent M.p. (*C) Yd (*)
3 Ph H +53* (1.0) MeOH 132 42
25 Ph 4-F +34* (0.5) 129 66
26 Ph 4-F -33* (0.5) EtOH 129 66
27 3-FPh 4-F +29* (0.5) EtOH 130 43
28 3-FPh 4-F (-) - -
29 Ph 4-(4-FPh)O (+) gl&BB 25
30 Ph 4-(4-FPh)O -12* (0.4) EtOH glass 44
V 9 0 0 / V 6 /d/dV
3) Preparation of the optical isomers of 15 formula I in which p = 0:
The compounds of formula I in which p » 0 and R3 is a hydrogen atom are obtained from the compound of formula VII:
BAD ORIGINAL ft
AP Ο Ο Ο 4 6 1
by reacting the latter with dimethylformamide dimethyl acetal (DMFDMA). The reaction is carried out at a temperature between 10 and 100eC, in excess DMFDMA.
The compound of formula VII is prepared from 5 a compound of formula VIII:
oe *4 tc c
c o
Q <
by reaction of the latter with the compound of formula V, at a temperature between -20 and 40°C, in a solvent consisting of a cyclic or non-cyclic ether, optionally in the presence of a base. The base is chosen from nitrogenous organic bases such as triethylamine or pyridine.
The compounds of formula VIII can be obtained from the β-amino acid of formula VI by observing the method described by S. Levine in J. Am. Chem. Soc. of
1953, Volume 76, page 1392.
BAD ORIGINAL
AP Ο Ο Ο 4 6 1
The optically active compounds of formula I in which R3 is an optionally halogenated Cj-C2 alkyl radical and in which p « 0 or ρ 1 and M CH2 are obtained from the compound of formula IX:
ιυ·Λ_/ /-0 o
in which R3 represents a Cj-C3 alkyl radical, by reaction of the latter with the compound of formula V, under conditions deduced, by analogy, from the method set out in the article by J. P.
Branquet et al. in Bull. Soc. Chim. de France, 1965, (10), pp 2942-2954.
This same article gives a procedure at the end of which the compound of formula IX can be prepared from the β-amino acid of formula VI.
Second stage:
The method of access to the optically pure or greatly enriched α-amino acids of formula VI used in the above stage is specified in this second stage.
These α-amino acids can be obtained according to one of the following methods:
- either by diastereoselective synthesis and then suppression of the chiral moiety, as described by M. Chaari, A. Jenhi, J.P. Lavergne and P. Viallefont in Tetrahedron, 1991, Volume 4, pages 4619-4630,
- or by enzymatic resolution of the racemic m υ ο / -/ο ιαιαν
BAD ORIGINAL
Α,ρ 0 0 0 4 6 1 amide, for which method the following references may usefully be consulted:
R.M. Kellog, E.M. Meijer et al., J. Org. Chem., 1988, Volume 53, pages 1826-1828
D. Rossi and A. Calcagni, Experimentia, 1985, volume 41, pages 35-37,
- or by hydrolysis of a chiral eunino acid precursor such as, for example:
- a formyl amino acid of structure XI as described by Mackenzie and Clough, J. Chem. Soc., 1912, pp 390-397, or by D.J. Cram et al., J. Am. Chem. Soc., 1961, 83, pp 2183-89,
- a hydantoin of structure XII as described in published British Patent Application No. 1,201,168.
Rj , NHCHO r2' co2h
XI
o
-a (C c
c o
fi
Q <
The compounds of formulae XI or XII can be obtained by resolution of the corresponding racemic modification with a chiral compound as described by Mackenzie and Clough, J. Chem. Soc., 1912, pp 390-397, or by D.J. Cram et al., J. Am. Chem. Soc., 1961, 83. pp 2183-89, for the compound XI or as described in published International Patent Application No.
BAD ORIGINAL ft
AP Ο Ο Ο 4 6 1
9,208,702 for the compound XII.
Example 6: ( +) - (2SI-2-amino-2-phenvlpropionic acid (Compound No. 101 g (0.115 mol) of ( +)-(5S)-5-methyl-55 phenylhydantoin, 100 ml of water and 100 ml of 28% aqueous ammonia are introduced successively into a 1 litre autoclave. The medium is heated at 160°C for 15 hours. After cooling to room temperature, the solution is concentrated under reduced pressure. The white solid obtained is treated with 100 ml of ethyl acetate for 2 hours and then filtered and dried under vaccum at 80°C.
10.5 g of ( + ) -(2S)-2-amino-2-phenylpropionic acid are collected in the form of a white powder which has a decomposition temperature of 266®C (Yield 55 %?
[o]d7 c - +71.9° (+ or - 3.1°) (c = 0.8 in IN hydrochloric acid)).
In the same way, the following analogous compounds of formula Via were obtained:
AP/P/ Q 4 / 0 fl A A
NH2 co2h
Via
BAD ORIGINAL
AP Ο Ο Ο 4 6 1
Compound No. R* [<*]D (c) Solvent M.p. (*C) yd (%;
10 H + 72* (0.8) IN HC1 266 55
31 4-F (+) - 44
32 4-F (-) - 92
33 4-(4-FPh)O (+) - 87
34 4-(4-FPh)O (-) - 76
Example 9 Illustrates the preparation of the compounds of formula XII
Example 9: ( +) -(5S)-5-Methvl-5-phenylhvdantoin (Compound No, 35)
5.6 g (0.139 mol) of sodium hydroxide are added to a stirred suspension of 70.0 g (0.368 mol) of (5R,5S)-5-methyl-5-phenylhydantoin in 2000 ml of water.
The solution obtained is brought to 40®C and then
44.6 g (0.368 mol) of (+)-R-a-methylbenzylamine are added. The solution obtained is maintained at 50*C for 0.75 h and a white precipitate appears after 3 min. On completion of heating, the reaction medium is allowed to crystallize for 24 h, the crystals are then filtered, washed with 70 ml of water and pulled dry under an air stream for 2 h and there are recovered 45 g of a white solid which is added to 220 ml of IN hydrochloric acid at 10eC. The suspension obtained is stirred for 2 h, the crystals are then filtered, washed with 100 ml of water and pulled dry and then dried
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL έ
AP Ο Ο Π 4 6 1 under reduced pressure at 50®C for 15 h. There are thus recovered 23 g (0.121 mol) of (+)-(5S)-5-methyl-5phenylhydantoin in the form of an off-white solid melting at 242®C (Yield 66%; (e]£’’c « +113® (c « 1.0 in ethanol)).
In the same way, but using (-)-S-emethylbenzylamine, (—) — (5R)-5-methyl-5-phenylhydantoin is recovered in the form of an off-white solid melting at 248®C (Yield = 54%; [e]’’*c « +120® (c « 1.0 in ethanol)).
In the same way, the following analogous compounds of formula Xlla were obtained:
0.
Ql <
Compound No. Rs [a]D (c) Sol vent M.p. (°C) Yd (%)
35 H 4-113° (1.0) EtOH 242 66
36 H -120° (1.0) EtOH 248 54
37 4-F +111® (0.8) EtOH 230 44
38 4-F -114° (0.8) EtOH 230 31
39 4-(4-FPh)O 4-54° (0.5) EtOH 190 -
40 4-(4-FPh)O -57® (0.6) EtOH 189 40
BAD ORIGINAL ft
AP 0 0 0 4 6 1
Variant B:
According to a second variant of the process for the preparation of the optical isomers of formula I, the latter are obtained from the corresponding racemic compounds by high performance liquid chromatography on a chiral stationary phase. A chiral stationary phase of Pirkle type with D-phenylglycine grafts is preferred.
The racemic compounds corresponding to the 10 formula I are prepared according to the methods described in the three patent applications mentioned in the introduction to the present text.
The examples below illustrate the optically active derivatives of formula I obtained according to
Variant B of the process of preparation.
Example 7: Separation of the f + l and (-) enantiomers of the compound of the following formula (Compounds No. 1 and 2 )
AP/P/ 9 4 / 0 0 6 4 ft
The corrresponding racemic compound is 20 prepared according to a procedure analogous to that described in Example 1 of the already mentioned Patent
Application EP 551048. This racemic compound is
BAD ORIGINAL $
AP 0 0 0 4 6 1 dissolved in an eluent mixture composed of n-heptane, isopropanol and dichloromethane, in the respective proportion by weight of 93, 5 and 2 %.
2.3 ml of the mixture thus obtained are injected into the chiral, high performance chromatographic column with the following characteristics:
- column of Pirkle type, with a diameter of 10 mm and a length of 250 mm;
- support: 5 pm 100 angstrom silica containing ionic D-phenylglycine grafts.
The flow rate chosen is 10 ml/min and the detector used is a UV detector at 250 nm. The enantiomerically pure compounds are recovered by fractionation and concentration of the pure fractions.
The physical characteristics of the enantiomers obtained, namely the melting point M.p., the optical rotation [a]£°, measured in degrees for the compound dissolved in ethanol at a concentration of 0.5 g per 100 ml, and the retention time tR, have been collated in the table below:
AP/P/ 9 4 / 0 0 6 48
Compound No. M.p.(°C) t«3S° t» (in minutes)
1 138 +60.7 + or - 1.3 5.73
2 138 -59.6 + or - 0.9 6.55
BAD ORIGINAL ft
Example 8; Separation of the (+) and (-) enantiomers of the compound of the following formula (Compounds No. 3 and 4);
The corresponding racemic compound is prepared according to a procedure analogous to that described in Example 1 of the already mentioned Patent Application EP 599749. The corresponding (+) and (-) enantiomers (Compounds No. 3 and 4 respectively) are obtained by carrying out the separation in the same way as above. The volume injected into the chiral column is 1.5 ml. The optical rotation is measured after dissolving the compounds in methanol and appears with the other physical characteristics, identical to those determined above, in the table below:
ΔΡ/ΡΖ 9 4/ 0 0 6 4«
Compound No. M.p.(°C) [a)S° t« (in minutes)
3 132 +51.3 + or - 1.2 9.89
4 132 -53.2 + or - 1.3 11.17
Example 10: Separation of the (+) and (-) enantiomers of the compound of the following formula (Compounds No.
5 and 61 :
BAD ORIGINAL ft
AP 0 0 0 4 6 1
The corresponding racemic compound is prepared according to a procedure analogous to that described in Example 1 of Patent Application EP 599749 already mentioned in the example above. The corresponding (+) and (-) enantiomers (Compounds No. 5 and 6 respectively) are obtained by carrying out the separation in the same way as above. The results obtained are collated in the table below:
Compound M.p. [a]3° (c) Solvent Absolute
No. (°C) configuration
5 202 +32.3° (c = 0.5) MeOH S
6 202 -32.2° (c = 0.5) MeOH R
AP/P/ 94/00648
The absolute configuration of Compounds No. 1 to 4 was determined by chemical correlation with the absolute configuration of the corresponding a-amino acid described in the literature. The absolute configuration of Compounds No. 5 and 6 was determined by X-ray crystallography.
_____ Another subject of the inventing optically active compounds useiulr^spec rally as int^eT^nffH.ia + A_q_in^+rh7r^rftparation of +hA compounds
BAD ORIGINAL ft
AP Ο Ο Ο 4 6 1
The corresponding racemic compound is prepared according to a procedure analogous to that described in Example 1 of Patent Application EP 599749 already mentioned in the example above. The corresponding (+) and (-) enantiomers (Compounds No. 5 and 6 respectively) are obtained by carrying out the separation in the same way as above. The results obtained are collated in the table below:
Compound M.p. [a]™ (c) Solvent Absolute
No. (°C) configuration
5 202 +32.3° (c = 0.5) MeOH S
6 202 -32.2° (c = 0.5) MeOH R
AP/P/ 94/00648
The absolute configuration of Compounds No. 1 to 4 was determined by chemical correlation with the absolute configuration of the corresponding a-amino acid described in the literature. The absolute configuration of Compounds No. 5 and 6 was determined by X-ray crystallography.
BAD ORIGINAL ft
AP Ο Ο Ο 4 6 1
The following new optically active compounds useful as intermediates have the formulae III, IV, VI, VII, VIII and X:
H
III
R2 .
R'-C-N = C=S I co2r
IV
R\ NH?
X
R> CO2H VI
R2^/NH2 o7 n~R4
VIII
VII
R5
AP/P/ 94/09648 in which R1 to R5 have the same meanings as in the general formula I of the invention, and the compound of formula IX:
in which R1 and R? have the same meaning as above and R3 represents an optionally halogenated Cj-Cj alkyl radical,
BAD ORIGINAL £
APO0046 1 and the compound of formula XIlb:
in which R2 has the same meaning as above and R* represents a phenyl, phenoxy or pyridyloxy radical, these radicals optionally being substituted by 1 to 3 groups, which are identical or different, chosen from R7 as defined above.
The following examples illustrate the fungicidal properties of Compounds No. 1 to 6, 11 to 14 and 25 to 28 of formula (I) according to the invention.
In these examples, the racemic modification corresponding to enantiomeric Compounds 1 and 2 is recorded as 1+2. Likewise, the racemic modification corresponding to Compounds 3 and 4 is recorded as 3+4.
( More generally, the racemic modification corresponding to enantiomeric Compounds n and n+1 is recorded as n+(n+1,.
Example BI: In vivo test on Puccinia recondita (brown rust of wheat):
An aqueous suspension of the active material to be tested is prepared, by fine milling, having the following composition:
- active material: 60 mg
- Tween 80 surface-active agent (oleate of
BAD ORIGINAL
AP Ο Ο Ο 4 6 1 polycondensate of ethylene oxide with sorbitan) diluted to 10 % in water: 0.3 ml
- volume made up to 60 ml with water.
The active material to be tested is either one of the 2 enantiomers according to the invention or the corresponding racemic modification.
This aqueous suspension is then diluted with water to produce the desired concentration of active material.
Wheat of the Talent variety, in pots, sown on a 50/50 peat/pozzolana earth substrate, is treated at the 10 cm high stage by spraying the above aqueous suspension.
After 24 hours, an aqueous suspension of spores (100,000 sp/cm3) is sprayed on the wheat; this suspension was obtained from infected seedlings. The wheat is then placed for 24 hours in an incubation cell at approximately 2O’C and at 100 % relative humidity, and then for 7 to 14 days at 60 % relative humidity.
Monitoring of the condition of the seedlings is carried out between the 8th and 15th day after infection, by comparison with an untreated control. The concentration of active material tested, IC7S (expressed in ppm), at which 75 % inhibition of the disease is observed, is then determined.
The results are collated in the following table:
o
Q c
c ««k c
c c
BAD ORIGINAL
AP Ο Ο Ο 4 6 1
Compound No. IC7S (ppm)
1+2 330
1 37
2 >1000
3+4 330
3 110
4 >1000
5+6 330
5 110-330
6 >1000
11+12 37-110
11 12-37
12 -
13+14 37
13 12
14 -
25+26 12
25 -
26 >1000
27+28 37
27 4
28 -
Example Β2: In vivo test on Phvtophthora infestans (tomato late blight):
An aqueous suspension of the active material
BAD ORIGINAL
AP Ο Ο Ο 4 6 1 to be tested is prepared, by fine milling, having the following composition:
- active material: 60 mg
- Tween 80 surface-active agent (oleate of polycondensate of ethylene oxide with sorbitan) diluted to 10 % in water: 0.3 ml
- volume made up to 60 ml with water.
The active material to be tested is chosen from the same compounds as in the preceding example.
This aqueous suspension is then diluted with water to produce the desired concentration of active material.
Tomato seedlings (Marmande variety) are grown in pots. When these seedlings are one month old (5 to
6-leaf stage, 12 to 15 cm high), they are treated by spraying the above aqueous suspension at various concentrations of the compound to be tested.
After 24 hours, each seedling is infected by spraying with an aqueous suspension of spores (30,000 sp/cm3) of Phvtophthora infestans.
After this infecting, the tomato seedlings are incubated for 7 days at approximately 20°C in an atmosphere saturated with moisture.
Seven days after infecting, the results obtained in the case of the seedlings treated with the active material to be tested are compared with those obtained in the case of the seedlings used as controls. The concentration of active material tested, IC„
CX c
c
ΛΟ/ΓΗ bad ORIGINAL 05
AP Ο Ο Ο 4 6 1 (expressed in ppm), at which 75 % inhibition of the disease is observed, is then determined.
The results are collated in the following table:
Compound No. IC„ (ppm)
1+2 110
1 37
2 >1000
3+4 330
3 110
4 >1000
5+6 >1000
5 37
6 >1000
11+12 110
11 12-37
12 -
13+14 110
13 37
14 -
25+26 110
25 37
26 >1000
27+28 37
27 4-12
28 -
ΔΡ/ο/ 9 4 / η n fi 4 β
BAD ORIGINAL ft
AP 0 0 0 4 6 1
The invention also relates to the compositions for protecting plants against fungal diseases, comprising, in combination with one or more solid or liquid vehicles which are acceptable in agriculture and/or surface-active agents which are also acceptable in agriculture, one (or a number of) active material which is a compound of formula I.
In fact, for their practical use, the compounds according to the invention are rarely used on their own. Most often these compounds form part of compositions. These compositions, which can be used as fungicidal agents, contain, as active material, a compound according to the invention as described above as a mixture with solid or liquid vehicles which are acceptable in agriculture and surface-active agents which are also acceptable in agriculture. In particular, the customary inert vehicles and the customary surface-active agents can be used. These compositions also form part of the invention.
These compositions can also contain all kinds of other ingredients such as, for example, protective colloids, adhesives, thickening agents, thixotropic agents, penetration agents, stabilizing agents, sequestering agents and the like. More generally, the compounds used in the invention can be used in combination with any of the solid or liquid additives which correspond to the usual formulating techniques.
Generally, the compositions according to the
AP/P/ 9 4/ 0 0 6 48 bad original ft
AP ο 0 0 4 6 1 invention usually contain approximately 0.05 to 95 % (by weight) of a compound according to the invention (subsequently called active material), one or more solid or liquid vehicles and, optionally, one or more surface-active agents.
The term vehicle, in the present account, means a natural or synthetic, organic or inorganic material with which the compound is combined in order to facilitate its application to the plant, to seeds or to the soil. This vehicle is therefore generally inert and it has to be acceptable in agriculture, especially to the treated plant. The vehicle can be solid (clays, natural or synthetic silicates, silica, resins, waxes, solid fertilizers, and the like) or liquid (water, alcohols, especially butanol, and the like).
The surface-active agent can be an emulsifying, dispersing or wetting agent of ionic or nonionic type or a mixture of such surface-active agents. There may be cited, for example, salts of poly(acrylic acids), salts of lignosulphonic acids, salts of phenolsulphonic or naphthalenesulphonic acids, polycondensates of ethylene oxide with fatty alcohols or fatty acids or fatty amines, substituted phenols (especially alkylphenols or arylphenols), salts of esters of sulphosuccinic acids, derivatives of taurine (especially alkyltaurates), phosphoric esters of polycondensates of ethylene oxide with alcohols or phenols, esters of fatty acids and of polyols, and the
8V900/V6 /d/dV
BAD ORIGINAL
AP Ο Ο Ο 4 6 1 derivatives of the above compounds having sulphate, sulphonate or phosphate functional groups. The presence of at least one surface-active agent is generally indispensable where the compound and/or the inert vehicle are not soluble in water and where the vector agent of the application is water.
Thus, the compositions for agricultural use according to the invention can contain the active materials according to the invention within very wide limits, ranging from 0.05 % to 95 % (by weight). Their surface-active agent content is advantageously between O % and 40 % by weight. q
These compositions according to the invention C c
are themselves in fairly diverse, solid or liquid forms.
There may be mentioned, as solid composition forms, powders for dusting (containing the compound at a content of up to 100 %) and granules, especially those obtained by extrusion, by compacting, by 20 impregnation of a granulated vehicle, or by granulation from a powder (the content of the compound in these granules being between 0.5 and 80 % for the latter cases), tablets or effervescent tablets.
The compounds of formula (I) can also be used 25 in the form of powders for dusting; it is also possible to use a composition comprising 50 g of active material and 950 g of talc; it is also possible to use a composition comprising 20 g of active material, 10 g of
AD/m A
BAD ORIGINAL
AP Ο Ο 0 A 6 1 finely divided silica and 970 g of talc; these constituents are mixed and milled and the mixture is applied by dusting.
As composition forms which are liquid or 5 intended to constitute liquid compositions during application, there may be mentioned solutions, in particular water-soluble concentrates, emulsifiable concentrates, emulsions, suspension concentrates, aerosols, wettable powders (or sprayable powder), pastes or gels.
The emulsifiable or soluble concentrates most often comprise 10 to 80 % of active material, while the ready-to-apply solutions or emulsions contain 0.001 to 20 % of active material.
In addition to the solvent, the emulsifiable concentrates can contain, when this is necessary, 2 to 20 % of suitable additives such as the stabilizing agents, surface-active agents, penetration agents, corrosion inhibitors, dyes or adhesives mentioned above.
It is possible, by diluting these concentrates with water, to obtain emulsions of any desired concentration which are particularly suitable for application to crops.
By way of example, the composition of several emulsifiable concentrates will now be given:
O «<
<4
C c
0 ZQZQ V bad ORIGINAL
AP Ο Ο Ο 4 6 1
EC Example 1
- active material 400 g/1
- alkaline dodecylbenzenesulphonate 24 g/1
- condensate of 10 molecules of ethylene oxide with nonylphenol 16 g/1
- cyclohexanone 200 g/1
- aromatic solvent qs 1 litre
According to another emulsifiable concentrate formula, there are used:
EC Example 2
- active material 250 g
- epoxidized vegetable oil 25 g
- mixture of alkylarylsulphonate and of ether of polyglycol and fatty alcohols 100 g
- dimethylformamide 50 g
- xylene 575 g
The suspension concentrates, which can also be applied by spraying, are prepared so as to produce a stable fluid product which does not settle out and they generally contain from 10 to 75 % of active material, from 0.5 to 15 % of surface-active agents, from 0.1 to 10 % of thixotropic agents, from 0 to 10 % of suitable additives, such as antifoaming agents, corrosion inhibitors, stabilizing agents, penetration agents and adhesives and, as vehicle, water or an organic liquid in which the active material has little or no solubility: certain solid organic materials or inorganic salts can be dissolved in the vehicle to help
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL $
AP 0 0 0 4 6 1 in preventing sedimentation or as antifreeze for the water.
By way of example, the composition of a suspension concentrate will now be given:
SC Example 1
- active material 500
- polycondensate of ethylene oxide with tristyrylphenyl phosphate 50
- polycondensate of ethylene oxide with alkylphenol 50
- sodium polycarboxylate 20
- ethylene glycol 50
- organopolysiloxane oil (antifoam) 1
- polysaccharide 1.5
- water 316.5 g
g g
g g
g g
The wettable powders (or sprayable powders) are generally prepared so that they contain 20 to 95 % of active material, and they generally contain, in addition to the solid vehicle, from 0 to 30 % of a wetting agent, from 3 to 20 % of a dispersing agent and, when necessary, from 0.1 to 10 % of one or more stabilizing agents and/or other additives, such as penetration agents, adhesives, or anticaking agents, dyes, and the like.
In order to obtain the sprayable powders or wettable powders, the active materials are intimately mixed in suitable mixers with the additional substances and the mixture is milled in mills or other suitable
BAD ORIGINAL
Λ.Ρ Ο Ο Ο 4 6 1 grinders. Sprayable powders are thereby obtained whose wettability and suspensibility are advantageous; they can be suspended in water at any desired concentration and these suspensions can be used very advantageously in particular for application to plant leaves.
Instead of wettable powders, it is possible to produce pastes. The conditions and methods for producing and using these pastes are similar to those for the wettable powders or sprayable powders.
By way of example, various wettable powder (or sprayable powder) compositions will now be given: WP Example 1
- active material 50 %
- condensate of ethylene oxide with fatty alcohol (wetting agent) 2.5 %
- condensate of ethylene oxide with phenylethylphenol (dispersing agent) 5 %
- chalk (inert vehicle) 42.5 %
8V 9 0 0 / V 6 /d/dV
WP Example 2
- active material 10 %
- condensate of 8 to 10 mol of ethylene oxide with Cn branched-type synthetic oxo alcohol (wetting agent) 0.75 %
- neutral calcium lignosulphonate (dispersing agent) 12 %
- calcium carbonate (inert filler) qs 100 %
BAD ORIGINAL ft
AP Ο Ο Ο 4 6 1
WP Example 3:
This wettable powder contains the same ingredients as in the above example, in the proportions below:
- active material
- wetting agent
- dispersing agent
- calcium carbonate (inert filler)
WP Example 4:
- active material
- condensate of ethylene oxide with fatty alcohol (wetting agent,
- condensate of ethylene oxide with phenylethylphenol (dispersing agent, %
1.50 % %
qs 100 %
WP Example 5:
- active material 50 %
- mixture of anionic and nonionic surface-active agents (wetting agent) 2.5 %
- sodium lignosulphonate (dispersing agent) 5 %
- kaolin clay (inert vehicle) 42.5 %
The aqueous dispersions and emulsions, for example the compositions obtained by diluting a wettable powder or an emulsifiable concentrate according to the invention using water, are included within the general scope of the present invention. The
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL ft
AP Ο Ο Ο 4 6 1 emulsions can be of water-in-oil or oil-in-water type and they can have a thick consistency like that of a mayonnaise.
The compounds according to the invention can 5 be formulated in the form of water-dispersible granules also included in the scope of the invention.
These dispersible granules, with an apparent density generally between approximately 0.3 and 0.6, have a particle size generally between approximately
150 and 2,000 and preferably between 300 and 1,500 microns.
The active material content of these granules is generally between approximately 1 % and 90 %, and preferably between 25 % and 90 %.
The remainder of the granule is essentially composed of a solid filler and optionally of surface-active adjuvants which confer water( dispersibility properties on the granule. These ( granules can be essentially of two distinct types depending upon whether the filler used is soluble or insoluble in water. When the filler is water-soluble, it can be inorganic or, preferably, organic. Excellent results have been obtained with urea. In the case of an insoluble filler, the latter is preferably inorganic, such as, for example, kaolin or bentonite. It is then advantageously accompanied by surface-active agents (at an amount of 2 to 20 % by weight of the granule) of which more than half consists, for example, of at least
AP/P/ 94/00648
BAD ORIGINAL ft
AP Ο Ο Ο 4 6 1 one essentially anionic dispersing agent such as an alkali metal or alkaline-earth metal polynaphthalene sulphonate or an alkali metal or alkaline-earth metal lignosulphonate, the remainder consisting of nonionic or anionic wetting agents such as an alkali metal or alkaline-earth metal alkylnaphthalene sulphonate.
Moreover, although this is not indispensable, it is possible to add other adjuvants such as antifoaming agents.
The granule according to the invention can be prepared by mixing the required ingredients and then granulating according to several techniques known per se (pelletizer, fluid bed, atomizer, extrusion, and the like). Generally, the preparation is completed by crushing followed by sieving to the particle size chosen within the abovementioned limits. It is alternatively possible to use granules obtained as above and then impregnated with a composition ί containing the active material.
Preferably, it is obtained by extrusion, the preparation being carried out as shown in the examples below.
DG Example 1: Dispersible granules % by weight of active material and 10 % of urea in the pearl form are mixed in a mixer. The mixture is then milled in a pin mill. A powder is obtained which is moistened with approximately 8 % by weight of water. The damp powder is extruded in a
APZPZ ft 4 Z 0 0 6 4 ft
BAD ORIGINAL
AP Ο Ο Ο 4 6 1 perforated-cylinder extruder. A granule is obtained which is dried and then crushed and sieved so as to retain only the granules with a size between 150 and 2,000 microns respectively.
DG Example 2: Dispersible granules
The following constituents are mixed in a mixer:
- active material 75 %
- wetting agent (sodium alkylnaphthalene sulphonate) 2 %
- dispersing agent (sodium polynaphthalene sulphonate) 8 %
- water-insoluble inert filler (kaolin) 15 %
This mixture is granulated in a fluid bed, in the presence of water, and is then dried, crushed and sieved so as to produce granules of between 0.15 and 0.80 mm in size.
( These granules can be used alone or in solution or dispersion in water so as to produce the required dose. They can also be used to prepare combinations with other active materials, especially fungicides, the latter being in the form of wettable powders or of granules or aqueous suspensions.
As regards the compositions which are suitable for storing and transporting, they more advantageously contain from 0.05 to 95 % (by weight) of active substance.
Another subject of the invention is a process
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL ft
AP Ο Ο Ο 4 6 1 for the treatment of crops affected by or capable of being affected by fungal diseases, characterized in that an effective amount of an optically active compound of formula I is applied preventively or curatively.
The compounds of formula I are advantageously applied at doses of 0.005 to 5 kg/ha, and more specifically of 0.01 to 1 kg/ha.
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL &
AP ο 0 0 4 6 1
Hiring flow p»7ii;uU.·!* dcjcri'.*r9
Riy/cur iaven:;J’J ta *iu< rruitft.-T thj »arui ii n be r'r: «-ty-6 - 51 - l{vt Uix'iui t»ui whit I'nt ciahn « -

Claims (16)

1. An optically active 2-imidazolin-5-one or 2-imidazoline-5thione derivative of general formula I in which:
-W represents an oxygen or sulphur atom or an S=0 group; -M represents an oxygen or sulphur atom, or an optionally halogenated CH2 radical;
-p is an integer equal to 0 or 1;
-★ means an asymmetric carbon atom corresponding to a stereospecific configuration;
-R1 and R2 are different and represent:
- an alkyl or haloalkyl radical containing 1 to 6 carbon atoms or ~ _
- an alkoxyalkyl, alkylthioalkyl, alkylsulphonylalkyl, monoalkylaminoalkyl, alkenyl or alkynyl radical containing 2 to 6 carbon atoms or
- a dialkylaminoalkyl or cycloalkyl radical containing 3 to 7 carbon atoms or
- an aryl radical comprising phenyl, naphthyl, thienyl, furyl, pyridyl, benzothienyl, benzofuryl, quinolyl, isoquinolyl or methylenedioxyphenyl, optionally substituted by 1 to 3 groups chosen from R6 or
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL A
AP 0 0 0 4 6 1
- 52 - an arylalkyl, aryloxyalkyl, arylthioalkyl or arylsulphonylalkyl radical, the terms aryl and alkyl having the definitions given above or
- R1 and R2 can form, with the carbon to which they are bonded on the ring, a carbocycle or a heterocycle having from 5 to 7 atoms, it being possible for these rings to be fused to a phenyl, optionally substituted by 1 to 3 groups chosen from R6;
- R3 represents:
- a hydrogen or an optionally halogenated 0,-¾ alkyl radical, when p is equal to 0 or (M)p is a CH2 radical,
- an optionally halogenated C,-^ alkyl radical, when (M)p represents an oxygen or sulphur atom;
- R4 represents:
- the hydrogen atom or
- an alkyl group containing 1 to 6 carbon atoms or
- an alkoxyalkyl, alkylthioalkyl, haloalkyl, cyanoalkyl, thiocyanatoalkyl, alkenyl or alkynyl group containing 2 to 6 carbon atoms or
- a dialkylaminoalkyl, alkoxycarbonylalkyl or Nalkylcarbamoylalkyl group containing 3 to 6 carbon atoms or
- an Ν,Ν-dialkylcarbamoylalkyl group containing 4 to
8 carbon atoms or
- an aryl radical, comprising phenyl, naphthyl, thienyl, furyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, benzothienyl, benzofuryl, quinolyl, isoquinolyl or methylenedioxyphenyl, optionally
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL
AP 0 0 0 4 6 1
- 53 substituted by 1 to 3 groups chosen from R6 or
- an arylalkyl, aryloxyalkyl, arylthioalkyl or arylsulphonylalkyl radical, the terms aryl and alkyl having the definitions given above;
- R5 represents:
- H, except when R4 is H, or
- an alkyl, haloalkyl, alkylsulphonyl or haloalkylsulphonyl radical containing 1 to 6 carbon atoms or
- an alkoxyalkyl, alkylthioalkyl, acyl, alkenyl, alkynyl, haloacyl, alkoxycarbonyl, haloalkoxycarbonyl, alkoxyalkylsulphonyl or cyanoalkylsulphonyl radical containing 2 to 6 carbon atoms or
- an alkoxyalkoxycarbonyl, alkylthioalkoxycarbonyl or cyanoalkoxycarbonyl radical containing 3 to 6 carbon atoms or
- the formyl radical or
- a cycloalkyl, alkoxyacyl, alkylthioacyl, cyanoacyl, alkenylcarbonyl or alkynylcarbonyl radical containing 3 to 6 carbon atoms or
- a cycloalkylcarbonyl radical containing 4 to 8 carbon atoms or
- a phenyl; arylalkylcarbonyl, especially phenylacetyl and phenylpropionyl; arylcarbonyl, especially benzoyl, optionally substituted by 1 to 3 groups from R6; thienylcarbonyl; furylcarbonyl; pyridylcarbonyl; benzyloxycarbonyl;
furfuryloxycarbonyl; tetrahydrofurfuryloxycarbonyl;
AP/P/9 4 / 0 06 48
BAD ORIGINAL
AP 0 0 0 4 6 1
- 54 and thienylmethoxycarbonyl; pyridylmethoxycarbonyl; phenoxycarbonyl or (phenylthio)carbonyl, the phenyl being itself optionally substituted by 1 to 3 groups from R6; (alkylthio)carbonyl;
(haloalkylthio)carbonyl; (alkoxyalkylthio)carbonyl; (cyanoalkylthio)carbonyl; (benzylthio)carbonyl;
(furfurylthio)carbonyl;
(tetrahydrofurfurylthio)carbonyl;
(thienylmethylthio)carbonyl; (pyridylmethylthio)carbonyl or arylsulphonyl radical or
- a carbamoyl radical, optionally mono- or disubstituted by:
- an alkyl or haloalkyl group containing 1 to 6 carbon atoms or
- a cycloalkyl, alkenyl or alkynyl group containing 3 to 6 carbon atoms or
- an alkoxyalkyl, alkylthioalkyl or cyanoalkyl group containing 2 to 6 carbon atoms or '
- a phenyl, optionally substituted by 1 to 3 R6 groups;
- a sulphamoyl group, optionally mono- or disubstituted by:
- an alkyl or haloalkyl group containing 1 to 6 carbon atoms or
- a cycloalkyl, alkenyl or alkynyl group containing 3 to 6 carbon atoms or
- an alkoxyalkyl, alkylthioalkyl or cyanoalkyl group containing 2 to 6 carbon atoms or
8 V 9 0 0 / V 6 /d/dV
BAD ORIGINAL
AP Ο Ο Ο 4 6 1
- 55 - a phenyl, optionally substituted by 1 to 3 R6 groups;
- an alkylthioalkylsulphonyl group containing 3 to 8 carbon atoms or a cycloalkylsulphonyl group
5 containing 3 to 7 carbon atoms;
- R4 and R5, taken together, can also form, with the nitrogen atom to which they are attached, a pyrrolidino, piperidino, morpholino or piperazino, optionally substituted by an alkyl containing 1 to 3
10 carbon atoms, group;
- R6 represents:
- a halogen atom or
- an alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio or alkylsulphonyl radical containing 1
15 to 6 carbon atoms or
- a cycloalkyl, halocycloalkyl, alkenyloxy, alkynyloxy, alkenylthio or alkynylthio radical containing 3 to 6 carbon atoms or
- the nitro or cyano group or
20 - an amino radical, optionally mono- or disubstituted by an alkyl or acyl radical containing 1 to 6 carbon atoms or an alkoxycarbonyl radical containing 2 to 6 carbon atoms
- a phenyl, phenoxy or pyridyloxy radical, these
25 radicals optionally being substituted by 1 to 3 groups, which are identical or different, chosen from R7;
- R7 represents:
- a halogen atom chosen from fluorine, chlorine,
8 V 9 0 0 / V 6 /d/dV
BAD ORIGINAL
AP Ο Ο Ο 4 6 1
- 56 10 bromine or iodine, or
- a linear or branched alkyl radical containing from 1 to 6 carbon atoms, or
- a linear or branched alkoxy or alkylthio radical containing from 1 to 6 carbon atoms, or
- a linear or branched haloalkoxy or haloalkylthio radical containing from 1 to 6 carbon atoms, or
- a nitrile radical, or
- a nitro radical;
and agriculturally-acceptable salts of these compounds.
2. An optically active compound according to claim 1 of formula II:
AP/P/ 9 4/ 0 0 6 48
3. An optically active compound of formula II according to 20 claim 2 in which W represents an oxygen atom.
4. A compound according to claim 3, which is an S-(+) enantiomer of the compound of formula II in which W is an oxygen atom, R2 is a methyl, M is a sulphur atom, p is equal to 1, R3 is a methyl, R4 is a phenyl and R5 and R6 represent a
25 hydrogen atom.
5. A process for the preparation of a compound according to any one of claims 1 to 4, which is a compound of formula I in which p = 1, M = S and W = 0, by reaction of a compound of formula III:
bad original
AP Ο Ο Ο 4 6 1
Η
Ν /S
N-R4 in which W represents an oxygen atom, with the compound of formula R3X in which X represents chlorine, bromine or iodine or .a sulphate group or an
10 alkylsulfonyloxy or arylsulfonyloxy group, in a solvent and in the presence of a base, at a temperature between -5°C and +80 °C.
6. A process according to claim 5, wherein the solvent is chosen from ethers, cyclic ethers, alkyl esters, acetonitrile,
15 alcohols containing from 1 to 3 carbon atoms or aromatic solvents, preferably tetrahydrofuran.
7. A process according to claim 5, wherein the base is chosen from an alkoxide, preferably potassium tert-butoxide, an alkali metal or alkaline-earth metal hydroxide, an alkali metal
2 0 carbonate or a tertiary amine.
8. A process for the preparation of a compound according to any one of claims 1 to 4, which is a compound of formula I in which p = 1, M = O and W = 0, wherein the corresponding compound of formula I for which p = 1 and M = S is reacted with
25 an alcohol of formula R3OH in a solvent, in the presence of a strong base and at a temperature of between 50 and 80°C.
9. A process according to claim 8, wherein the strong base is chosen from an alkali metal hydroxide, a strong organic base or an alkali metal alkoxide of formula R3O'Met* in which Met*
AP/P/ 9 4 / 0 0 6 48
BAD ORIGINAL
AP 0 Ο Ο 4 6 1 represents an alkali metal or an alkaline-earth metal.
10. A process according to claim 8, wherein the reaction is carried out by using the alcohol R3OH as solvent and the sodium alkoxide R3O'Na+ as base.
11. A process for the preparation of a compound according to any one of claims 1 to 4 which is a compound of formula I in which p = O and R3 is a hydrogen atom, by reaction of a compound of formula VII:
H
O
N-R4
I with an excess of dimethylformamide dimethyl acetal at a temperature between 10 and 100°C.
12. A process for the preparation of a compound according to any one of claims 1 to 3 which is a compound of formula I in
AP/P/ 9 4 / 0 0 6 48 which R3 is an optionally halogenated C,-^ alkyl radical, p = 0 or 1 and M = CH2, by reaction of a compound of formula IX:
with a compound of formula V:
R4—N—NH-, I 2
R5
BAD ORIGINAL ft
AP 0 Ο Ο 4 6 1
- 59 in which R3 represents an optionally halogenated C^-C-j alkyl radical, and R1 and R2 are as defined in claim 1, and of formula Xllb:
in which R2 is as defined in claim 1 and R6 represents a phenyl, phenoxy or pyridyloxy radical, optionally substituted by 1 to 3 groups, which are identical or different, chosen from R7 as defined in claim 1.
14. A compound according to claim 13, wherein in the formulae III, IV, VI, VII, VIII and IX, R1 is phenyl and R2 is methyl.
15. A fungicidal composition comprising, in combination with one or more solid or liquid vehicles which are acceptable in agriculture and/or surface-active agents which are acceptable in agriculture, one or more active materials chosen from the compounds of formula I according to any one of claims 1 to 4.
16. A method of treating a crop affected by or capable of being affected by a fungal disease, wherein an effective amount of an optically active compound of formula I according to any one of claims 1 to 4 is applied preventively or curatively.
17. A method according to claim 16, wherein the compound of formula I is applied at a dose of 0.005 to 5 kg/ha, preferably of 0.01 to 1 kg/ha.
APAP/P/1994/000648A 1993-06-18 1994-06-16 "Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives". AP461A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9307663A FR2706455B1 (en) 1993-06-18 1993-06-18 Optically active derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones fungicides.
FR9402144A FR2706456B1 (en) 1993-06-18 1994-02-21 Optically active derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones fungicides.

Publications (2)

Publication Number Publication Date
AP9400648A0 AP9400648A0 (en) 1994-07-31
AP461A true AP461A (en) 1996-02-17

Family

ID=26230430

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000648A AP461A (en) 1993-06-18 1994-06-16 "Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives".

Country Status (36)

Country Link
US (3) US6018052A (en)
EP (1) EP0629616B1 (en)
JP (1) JP3844793B2 (en)
KR (1) KR100348201B1 (en)
CN (4) CN1230425C (en)
AP (1) AP461A (en)
AT (1) ATE204865T1 (en)
AU (1) AU690107B2 (en)
BG (1) BG62329B1 (en)
BR (1) BR9401828A (en)
CA (1) CA2125236C (en)
CO (1) CO4180381A1 (en)
CZ (1) CZ287317B6 (en)
DE (1) DE69428080T2 (en)
DK (1) DK0629616T3 (en)
EG (1) EG20455A (en)
ES (1) ES2160114T3 (en)
FI (1) FI119842B (en)
FR (1) FR2706456B1 (en)
HK (3) HK1062908A1 (en)
HR (1) HRP940351B1 (en)
HU (2) HU9802837D0 (en)
IL (3) IL110023A (en)
MA (1) MA23226A1 (en)
MY (1) MY115311A (en)
NZ (1) NZ260768A (en)
PE (1) PE57094A1 (en)
PL (1) PL177934B1 (en)
PT (1) PT629616E (en)
RO (1) RO113858B1 (en)
RU (1) RU2126390C1 (en)
SI (1) SI0629616T1 (en)
SK (1) SK283708B6 (en)
TR (1) TR28762A (en)
TW (1) TW304192B (en)
UA (1) UA44219C2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685328B1 (en) * 1991-12-20 1995-12-01 Rhone Poulenc Agrochimie DERIVATIVES OF 2-IMIDAZOLINE-5-ONES AND 2-IMIDAZOLINE-5-THIONES FUNGICIDES.
FR2698359B1 (en) * 1992-11-25 1995-10-27 Rhone Poulenc Agrochimie DERIVATIVES OF 2-ALKOXY 2-IMIDAZOLINE-5-ONES FUNGICIDES.
FR2722499B1 (en) * 1994-07-13 1996-08-23 Rhone Poulenc Agrochimie NEW 2-IMIDAZOLINE-5-ONES FUNGICIDE DERIVATIVES
FR2722652B1 (en) * 1994-07-22 1997-12-19 Rhone Poulenc Agrochimie FUNGICIDE COMPOSITION COMPRISING A 2-IMIDAZOLINE-5-ONE
FR2778671B1 (en) * 1998-05-14 2002-07-05 Rhone Poulenc Agrochimie NEW PROCESS FOR THE PREPARATION OF SYNTHESIS INTERMEDIATES
FR2783401B1 (en) * 1998-09-21 2000-10-20 Rhone Poulenc Agrochimie NEW FUNGICIDAL COMPOSITIONS
FR2788271B1 (en) * 1999-01-07 2001-02-09 Rhone Poulenc Agrochimie NEW PROCESS FOR THE PREPARATION OF CHIRAL AMINO ACIDS
DE19917617A1 (en) * 1999-04-19 2000-10-26 Bayer Ag New (-) enantiomer of 2-(2-(1-chloro-cyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl)-2,4-dihydro-(1,2,4)-triazole useful as a microbicide, especially fungicide, in plant and material protection
FR2794743A1 (en) * 1999-06-09 2000-12-15 Aventis Cropscience Sa NOVEL PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALPHA-AMINONITRILES
PT1185173E (en) * 1999-06-14 2003-10-31 Syngenta Participations Ag FUNGICIDAL COMBINATIONS
FR2800734B1 (en) * 1999-11-05 2002-08-23 Aventis Cropscience Sa CHIRAL AMINO ACID CRYSTAL AND PROCESS FOR PREPARING THE SAME
DE10019758A1 (en) 2000-04-20 2001-10-25 Bayer Ag Fungicidal combinations containing known methoxyimino-acetic acid amide derivatives useful for the control of phytopathogenic fungi
DE10103832A1 (en) * 2000-05-11 2001-11-15 Bayer Ag Synergistic combination of fungicides for use in plant protection, comprises 2-(pyrimidinyloxy-phenyl)-2-(methoxyimino)-N-methyl-acetamide derivative and e.g. spiroxamine, quinoxyfen or tebuconazole
DE10049804A1 (en) * 2000-10-09 2002-04-18 Bayer Ag Agent containing synergistic mixture comprising phenyl-pyrroline ketoenol derivatives with fungicides and acaricides useful especially in plant protection
US6759551B1 (en) 2000-11-03 2004-07-06 Bayer Cropscience S.A. Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same
FR2821718B1 (en) * 2001-03-08 2003-06-13 Aventis Cropscience Sa NOVEL FUNGICIDAL COMPOSITIONS BASED ON PYRIDYLMETHYLBENZAMIDE AND IMIDAZOLINE OR OXAZOLIDINE DERIVATIVES
AU2003220222A1 (en) 2002-03-13 2003-09-29 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
KR100983437B1 (en) 2002-04-24 2010-09-20 바스프 에스이 Use of certain alcohol alkoxylates as adjuvants in agricultural technology
DE10347090A1 (en) 2003-10-10 2005-05-04 Bayer Cropscience Ag Synergistic fungicidal drug combinations
DE10349501A1 (en) 2003-10-23 2005-05-25 Bayer Cropscience Ag Synergistic fungicidal drug combinations
WO2005090316A1 (en) * 2004-03-12 2005-09-29 Wyeth HYDANTOINS HAVING RNase MODULATORY ACTIVITY
DE102004049761A1 (en) 2004-10-12 2006-04-13 Bayer Cropscience Ag Fungicidal drug combinations
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
EP1843734A4 (en) 2005-02-03 2008-09-10 Signum Biosciences Inc Compositions and methods for enhancing cognitive function
MX2007015376A (en) 2005-06-09 2008-02-14 Bayer Cropscience Ag Active substance combinations.
DE102005026482A1 (en) 2005-06-09 2006-12-14 Bayer Cropscience Ag Active substance combination, useful e.g. for combating unwanted phytopathogenic fungus, comprises herbicides e.g. glyphosate and active substances e.g. strobilurin, triazoles, valinamide and carboxamide
ITMI20051558A1 (en) 2005-08-09 2007-02-10 Isagro Spa MIXTURES E-O SYNERGIC COMPOSITIONS CIN HIGH ACTIVITY FEATURES
CL2007003743A1 (en) 2006-12-22 2008-07-11 Bayer Cropscience Ag COMPOSITION THAT INCLUDES FENAMIDONA AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY.
DE102007045920B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistic drug combinations
CA2758424C (en) 2008-04-21 2018-03-06 Signum Biosciences, Inc. Tryptamine derivatives as pp2a methylation modulators
MX2012000566A (en) 2009-07-16 2012-03-06 Bayer Cropscience Ag Synergistic active substance combinations containing phenyl triazoles.
JP5788404B2 (en) * 2009-12-11 2015-09-30 アウトイフオンイ トヘラペウトイクス リミテッド Imidazolidinedione derivatives
JP5956980B2 (en) * 2010-05-19 2016-07-27 サンド・アクチエンゲゼルシヤフト Process for the preparation of chiral compounds
CN103081915A (en) * 2011-11-07 2013-05-08 深圳诺普信农化股份有限公司 Bactericidal composition
EP2622961A1 (en) 2012-02-02 2013-08-07 Bayer CropScience AG Acive compound combinations
CN102919250A (en) * 2012-11-14 2013-02-13 陕西农心作物科技有限公司 Sterilizing composition containing benthiavalicarb isopropyl
JPWO2015037243A1 (en) * 2013-09-12 2017-03-02 興和株式会社 Method for producing optically active hydantoin compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551048A1 (en) * 1991-12-20 1993-07-14 Rhone-Poulenc Agrochimie 2-imidazoline-5-one and 2-imidazoline-5-thiones derivatives as fungizides
WO1994001410A1 (en) * 1992-07-02 1994-01-20 Rhone Poulenc Agrochimie Fungicidal 2-imidazoline-5-one and 2-imidazoline-5-thione derivatives
EP0599749A1 (en) * 1992-11-25 1994-06-01 Rhone-Poulenc Agrochimie 2-alkoxy-2-imidazoline-5-one derivatives as fungicides

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB967167A (en) * 1960-10-31 1964-08-19 Ici Ltd N-trichloromethylmercaptohydantoins and fungicidal compositions containing them
NL257812A (en) * 1959-11-10
BE623153A (en) * 1961-10-04
DE1176660B (en) * 1963-07-05 1964-08-27 Beiersdorf & Co A G P Process for the preparation of triaryl-substituted imidazolinones-4 (5)
GB1026509A (en) * 1963-08-13 1966-04-20 Novalis Lab New derivatives of n-substituted ª‡-amino acids and processes for their production
DE1258412B (en) * 1964-08-29 1968-01-11 Beiersdorf Ag Process for the preparation of 5,5-bis- (p-hydroxyphenyl) -imidazolinonen- (4) and their salts
GB1167192A (en) * 1967-12-19 1969-10-15 Boots Pure Drug Co Ltd Improvements in the Preparation of Propionic Acids
FR2329276A1 (en) * 1975-10-29 1977-05-27 Roussel Uclaf NEW SUBSTITUTES IMIDAZOLIDINES, METHOD OF PREPARATION, APPLICATION AS A MEDICINAL PRODUCT AND COMPOSITIONS CONTAINING THEM
DE2658941A1 (en) * 1976-12-24 1978-07-06 Basf Ag Diastereomeric 4,4-di:substd.-2-imidazolin-5-one derivs. - prepd. by asymmetric induction, intermediates for optically pure aminoacid(s) such as methyl-DOPA
US4280008A (en) * 1976-12-24 1981-07-21 Basf Aktiengesellschaft Chirally substituted 2-imidazolin-5-ones
US4428948A (en) * 1977-02-03 1984-01-31 Rohm And Haas Company Novel heterocyclic compounds
IL57504A0 (en) * 1978-06-15 1979-10-31 Beecham Group Ltd Prostagandin analogues,their preparation and pharmaceutical compositions containing
US4459411A (en) * 1982-09-13 1984-07-10 The Dow Chemical Company Preparation of unsaturated heterocyclic carbonyl-containing compounds
DE3305203A1 (en) * 1983-02-16 1984-08-16 Bayer Ag, 5090 Leverkusen N-SULFENYLATED HYDANTOINE, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MICROBICIDE
DE3340595A1 (en) * 1983-11-10 1985-05-23 Hoechst Ag, 6230 Frankfurt IMIDAZOLINONES, METHOD FOR THEIR PRODUCTION AND THEIR USE IN PLANT PROTECTION
US4692532A (en) * 1984-11-23 1987-09-08 Ciba-Geigy Corporation Substituted N-(4-hydroxyphenylthioalkyl) cyclic imides
US4657922A (en) * 1985-05-24 1987-04-14 Mcneilab, Inc. Anxiolytic 4,5-dihydro-4-oxo-1H-imidazol-2-yl urea derivatives
AU1543488A (en) * 1987-03-20 1988-10-10 E.I. Du Pont De Nemours And Company Fungicidal aminotriazoles and aminoimidazoles
EP0303863A3 (en) * 1987-08-17 1991-10-23 American Cyanamid Company Benzenesulfonyl carboxamide compounds, intermediate compounds and methods of preparation thereof and use of said compounds and intermediate compounds as herbicidal agents
JPH0219363A (en) * 1988-07-06 1990-01-23 Fujisawa Pharmaceut Co Ltd Imidazolidine derivative
US4931582A (en) * 1988-11-04 1990-06-05 Minnesota Mining And Manufacturing Company Fluorinated, acrylamide-functional monomers
US4957933A (en) * 1989-04-21 1990-09-18 E. I. Du Pont De Nemours And Company Fungicidal oxazolidinones
US5213607A (en) * 1989-12-20 1993-05-25 American Cyanamid Company 2-(1-substituted-2-imidazolin-2-yl) benzoic and nicotinic acids and method for their preparation
FR2671348B1 (en) * 1991-01-09 1993-03-26 Roussel Uclaf NOVEL PHENYLIMIDAZOLIDINES, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
RU2059603C1 (en) * 1991-05-09 1996-05-10 Хоффманн-Ля Рош АГ Derivatives of &&&-substituted arylacetic acids and pharmaceutical composition
US5177097A (en) * 1991-07-24 1993-01-05 E. R. Squibb & Sons, Inc. Acyl amidine and acyl, guanidine substituted biphenyl derivatives
US6002016A (en) * 1991-12-20 1999-12-14 Rhone-Poulenc Agrochimie Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones
EP1008589A1 (en) * 1992-05-22 2000-06-14 E.I. Du Pont De Nemours & Company Incorporated Fungicidal imidazolinones
US6013052A (en) * 1997-09-04 2000-01-11 Ep Technologies, Inc. Catheter and piston-type actuation device for use with same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551048A1 (en) * 1991-12-20 1993-07-14 Rhone-Poulenc Agrochimie 2-imidazoline-5-one and 2-imidazoline-5-thiones derivatives as fungizides
WO1994001410A1 (en) * 1992-07-02 1994-01-20 Rhone Poulenc Agrochimie Fungicidal 2-imidazoline-5-one and 2-imidazoline-5-thione derivatives
EP0599749A1 (en) * 1992-11-25 1994-06-01 Rhone-Poulenc Agrochimie 2-alkoxy-2-imidazoline-5-one derivatives as fungicides

Also Published As

Publication number Publication date
PL303864A1 (en) 1995-01-09
BG62329B1 (en) 1999-08-31
EP0629616B1 (en) 2001-08-29
MY115311A (en) 2003-05-31
IL122339A0 (en) 1998-04-05
RU2126390C1 (en) 1999-02-20
RO113858B1 (en) 1998-11-30
CZ287317B6 (en) 2000-10-11
CZ149194A3 (en) 1995-01-18
US6018052A (en) 2000-01-25
CN1129583C (en) 2003-12-03
HUT67152A (en) 1995-02-28
US6344564B1 (en) 2002-02-05
TW304192B (en) 1997-05-01
AU6458694A (en) 1994-12-22
EP0629616A2 (en) 1994-12-21
RU94021649A (en) 1996-04-20
DK0629616T3 (en) 2001-10-08
HK1066010A1 (en) 2005-03-11
NZ260768A (en) 1996-02-27
CA2125236C (en) 2007-11-20
HK1062908A1 (en) 2004-12-03
EG20455A (en) 1999-04-29
CN1230425C (en) 2005-12-07
TR28762A (en) 1997-02-20
CN1229336C (en) 2005-11-30
HRP940351A2 (en) 1996-12-31
UA44219C2 (en) 2002-02-15
HU9401829D0 (en) 1994-09-28
AP9400648A0 (en) 1994-07-31
FI942911A0 (en) 1994-06-17
KR100348201B1 (en) 2002-11-18
US5650519A (en) 1997-07-22
DE69428080D1 (en) 2001-10-04
AU690107B2 (en) 1998-04-23
HU9802837D0 (en) 1999-02-01
CA2125236A1 (en) 1994-12-19
FI942911A (en) 1994-12-19
KR950000670A (en) 1995-01-03
PL177934B1 (en) 2000-01-31
MA23226A1 (en) 1994-12-31
ES2160114T3 (en) 2001-11-01
CO4180381A1 (en) 1995-06-07
CN1480451A (en) 2004-03-10
CN1265394A (en) 2000-09-06
FR2706456B1 (en) 1996-06-28
IL122339A (en) 1999-12-31
SI0629616T1 (en) 2001-12-31
JP3844793B2 (en) 2006-11-15
CN1511832A (en) 2004-07-14
SK283708B6 (en) 2003-12-02
PE57094A1 (en) 1995-02-07
CN1055465C (en) 2000-08-16
SK73994A3 (en) 1995-03-08
IL110023A0 (en) 1994-10-07
JPH07330737A (en) 1995-12-19
HU221038B1 (en) 2002-07-29
BR9401828A (en) 1995-01-17
ATE204865T1 (en) 2001-09-15
PT629616E (en) 2002-02-28
CN1106803A (en) 1995-08-16
BG98855A (en) 1995-05-31
DE69428080T2 (en) 2002-04-11
FI119842B (en) 2009-04-15
FR2706456A1 (en) 1994-12-23
HK1029341A1 (en) 2001-03-30
IL110023A (en) 1999-12-31
EP0629616A3 (en) 1995-05-24
HRP940351B1 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
AP461A (en) &#34;Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives&#34;.
CA2085192C (en) Fungicidal derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones
US5637729A (en) Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones
AP496A (en) Fungicidal 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives.
US6008370A (en) Fungicidal-2-alkoxy/haloalkoxy-1-(mono- or disubstituted)amino-4,4-disubstituted-2-imidazolin-5-ones
FR2721022A1 (en) Derivatives of 5-imino 2-imidazolines fungicides.